Analysis

LUXH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that LuxUrban Hotels Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
Tuesday, April 2, 2024
Letter, Defendant, News, Complaint, Person, Royalton Hotel, Result, Analysis, Court

In November 2023, the Company announced it had signed a 25-year Master Lease Agreement (“MLA”) with the prestigious Royalton Hotel in New York.

Key Points: 
  • In November 2023, the Company announced it had signed a 25-year Master Lease Agreement (“MLA”) with the prestigious Royalton Hotel in New York.
  • On January 17, 2024, Bleecker Street Research published a report, which alleged that the Company had not actually signed a lease with the Royalton Hotel.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against LuxUrban Hotels Inc. - LUXH

Retrieved on: 
Sunday, March 31, 2024
Letter, News, Ext, Complaint, Royalton Hotel, Pomerantz, Action Replay, Result, Analysis, Court

NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against LuxUrban Hotels Inc. (“LuxUrban” or the “Company”) (NASDAQ: LUXH).

Key Points: 
  • NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against LuxUrban Hotels Inc. (“LuxUrban” or the “Company”) (NASDAQ: LUXH).
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • The class action concerns whether LuxUrban and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Osisko Files 2023 Year-End Disclosure Documents

Retrieved on: 
Thursday, March 28, 2024
Osisko Gold Royalties, Form, 2S2, Management, Suite, TSX, Annual report, Analysis, Conversation, Cryptocurrency

MONTRÉAL, March 28, 2024 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (TSX & NYSE:OR) announces that its Annual Information Form, Consolidated Annual Financial Statements and Management's Discussion and Analysis for the year ended December 31, 2023 have been filed with Canadian securities regulatory authorities.

Key Points: 
  • MONTRÉAL, March 28, 2024 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (TSX & NYSE:OR) announces that its Annual Information Form, Consolidated Annual Financial Statements and Management's Discussion and Analysis for the year ended December 31, 2023 have been filed with Canadian securities regulatory authorities.
  • Osisko has also filed its Annual Report on Form 40-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission.
  • Copies of these documents may be obtained via www.sedar.com , www.sec.gov (for the Form 40-F) or www.osiskogr.com .
  • Shareholders may also receive a hard copy of these documents without charge upon request to Osisko’s Investor Relations Department, 1100 av.

Dyadic Reports 2023 Full Year Results and Recent Company Progress

Retrieved on: 
Thursday, March 28, 2024
Cygnus, Enzyme, Rabies, SAHPRA, Biology, Sale, Innovation, Infection, Note, European, AVATAR, Therapy, Host cell protein, Vaccine, Analysis, Convertible, Research, Biotechnology, A-DNA, Massachusetts General Hospital, Partnership, Melamaravakkadu, Webcast, Primate, RNA, Biofuel, C1, Virology, SME, Safety, Nature Communications, Transferrin, Livestock, Global health, Manuscript, Food, Senior, NIIMBL, Antibody, Hospital, Antigen, Diagnosis, Health, Pithing, RBD, Phibro Animal Health, COVID-19, Dyadic, Messenger, Protein, Human

“In 2023, Dyadic achieved significant milestones in unlocking the potential of its microbial platforms.

Key Points: 
  • “In 2023, Dyadic achieved significant milestones in unlocking the potential of its microbial platforms.
  • We believe that we are well-positioned, both financially and scientifically, to execute our strategic plan with enhanced capabilities and resources.
  • For the year ended December 31, 2023, the Company received a total of approximately $1.3 million in connection with the sale of Alphazyme LLC.
  • Other Income: For the year ended December 31, 2023, the Company had a gain of approximately $1,018,000 from the sale of the Company’s equity interest in Alphazyme, LLC.

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LuxUrban

Retrieved on: 
Thursday, March 28, 2024
Letter, News, LLP, MLA, Royalton Hotel, Advertising, Result, Analysis, Court, Conversation, Property management

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.

Key Points: 
  • Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • The firm has recovered hundreds of millions of dollars for investors since its founding in 1995.
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding LuxUrban’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
  • The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).

Cost of adding undue energy conservation measures reach tipping point: RESCON

Retrieved on: 
Wednesday, March 27, 2024
Electricity, Climate change, Tax, Country Homes, Washington, Policy, Housing, Analysis, Natural Resources Canada, Real estate

“Through regulatory mandates, there is a move to fully electrify all new buildings and homes to meet net-zero targets in order to combat climate change,” says RESCON president Richard Lyall.

Key Points: 
  • “Through regulatory mandates, there is a move to fully electrify all new buildings and homes to meet net-zero targets in order to combat climate change,” says RESCON president Richard Lyall.
  • Findings showed discrepancies between annual energy use simulation software and the homes’ actual performance, consuming more energy than predicted.
  • Given the ongoing housing affordability crisis, the limited energy savings homeowners realize from added conservation measures do not always justify the incremental construction costs imposed on new housing.
  • RESCON is the province’s leading association of residential builders committed to providing leadership and fostering innovation in the industry.

Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2023

Retrieved on: 
Wednesday, March 27, 2024
Financial statement, Growth, Infertility, International, IVF, Travel, EDT, Acquisition, Laboratory, Consumables, Adjustment, Investment, Depreciation, Analysis, Marketing, Hand, Bookkeeping

Results of Operations for the Year ended December 31, 2023

Key Points: 
  • Results of Operations for the Year ended December 31, 2023
    Hamilton Thorne sales increased 16% to $67,225,476 for the year-ended December 31, 2023, an increase of $9,047,409 from $58,178,067 during the previous year.
  • Consumable sales in 2023 outpaced the Company’s overall growth despite being affected by the recall of certain products by one of the Company’s contract manufacturers.
  • We are expecting first quarter 2024 reported revenues of between $19.0 to 19.4M, with organic growth for the quarter of approximately 8%.
  • Financial Statements and accompanying Management Discussion and Analysis for the periods are available on www.sedar.com and the Hamilton Thorne website.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against LuxUrban Hotels Inc. (LUXH)

Retrieved on: 
Wednesday, March 27, 2024
Letter, GPM, Defendant, News, Suite, Royalton Hotel, Result, Analysis, Court, Property management

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • In November 2023, the Company announced it had signed a 25-year Master Lease Agreement (“MLA”) with the prestigious Royalton Hotel in New York.
  • The report stated the owner of the Royalton hotel building confirmed LuxUrban never actually signed a lease, nor even provided a Letter of Credit.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

Retrieved on: 
Wednesday, March 27, 2024
Diagnosis, Patient, Research, Sale, Management, Net, Bank statement, TSX, Safety, Canada Business Corporations Act, Result, Analysis, Conversation, Cryptocurrency

TORONTO, ONTARIO, March 27, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today reported its financial and operating results for the year ended December 31, 2023 and provided an update on the completion of enrollment for its ongoing Phase 3 safety and efficacy study AEZS-130-P02 (the "DETECT-trial") evaluating macimorelin for the diagnosis of Childhood Onset Growth Hormone Deficiency ("CGHD").

Key Points: 
  • The Company completed enrollment of all patients in the DETECT-trial and expects that the last patient will receive the patient’s first growth hormone stimulation test using macimorelin in April 2024.
  • The study included approximately 100 subjects in Europe and North America.
  • Dr. Klaus Paulini, Chief Executive Officer of Aeterna commented, “With enrollment now completed in the DETECT-trial, we expect the completion of the DETECT-trial in the second quarter and Top-Line Data in the third quarter of this year.
  • The Company had $34.0 million in cash and cash equivalents at December 31, 2023.

LUXH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that LuxUrban Hotels Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
Tuesday, March 26, 2024
Letter, Defendant, News, Complaint, Person, Royalton Hotel, Result, Analysis, Court

In November 2023, the Company announced it had signed a 25-year Master Lease Agreement (“MLA”) with the prestigious Royalton Hotel in New York.

Key Points: 
  • In November 2023, the Company announced it had signed a 25-year Master Lease Agreement (“MLA”) with the prestigious Royalton Hotel in New York.
  • On January 17, 2024, Bleecker Street Research published a report, which alleged that the Company had not actually signed a lease with the Royalton Hotel.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.